Ryan Maynard

Ryan Maynard

Director of Finance/CFO chez CARA THERAPEUTICS, INC.

Fortune : 12 285 $ au 31/03/2024

54 ans
Health Technology
Technology Services
Electronic Technology

Profil

Ryan D.
Maynard
is currently serving as the Chief Financial Officer at CARA Therapeutics, Inc. since 2022 and as an Independent Director at Iovance Biotherapeutics, Inc. since 2015.
He also holds the position of Chief Financial Officer at Paulus (Holdings) Ltd.
Additionally, Mr. Maynard has previously worked as the Controller, Director-Finance & Accounting at Personify, Inc. (California) from 1999 to 2001, Senior Manager-Finance at Siliconix, Inc. from 1994 to 1998, Controller at General Magic, Inc. from 1998 to 1999, CFO, Executive VP & Head-Investor Relations at Rigel Pharmaceuticals, Inc. from 2001 to 2017, Chief Financial Officer at Blade Therapeutics, Inc. from 2018 to 2019, and Chief Financial Officer at LetsGetChecked, Inc. from 2019 to 2022.
Mr. Maynard completed his undergraduate degree at Santa Clara University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
01/02/2024 13 500 ( 0,02% ) 12 285 $ 31/03/2024
01/03/2024 0 ( -.--% ) - $ 31/03/2024

Postes actifs de Ryan Maynard

SociétésPosteDébut
IOVANCE BIOTHERAPEUTICS, INC. Director/Board Member 16/02/2015
CARA THERAPEUTICS, INC. Director of Finance/CFO 12/09/2022
Director of Finance/CFO -
Tous les postes actifs de Ryan Maynard

Anciens postes connus de Ryan Maynard

SociétésPosteFin
Director of Finance/CFO 01/03/2022
Director of Finance/CFO 01/06/2019
RIGEL PHARMACEUTICALS, INC. Director of Finance/CFO 31/12/2017
Director of Finance/CFO 01/04/2001
GENERAL MAGIC, INC. Comptroller/Controller/Auditor 01/10/1999
Voir l'expérience en détail de Ryan Maynard

Formation de Ryan Maynard

Santa Clara University Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Ryan Maynard

Relations

94

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
RIGEL PHARMACEUTICALS, INC.

Health Technology

CARA THERAPEUTICS, INC.

Health Technology

IOVANCE BIOTHERAPEUTICS, INC.

Health Technology

Entreprise privées6

Electronic Technology

Technology Services

Technology Services

Commercial Services

Health Technology

Finance

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Ryan Maynard